Literature DB >> 23553621

Quantification of JAK2V617F mutation by next-generation sequencing technology.

Emna Abdelhamid, Martin Figeac, Aline Renneville, Sabine Quief, Céline Villenet, Thomas Boyer, Olivier Nibourel, Valerie Coiteux, Bruno Cassinat, Eric Lippert, Nathalie Helevaut, Zohra Soua, Claude Preudhomme.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23553621     DOI： 10.1002/ajh.23446

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Positive impact of molecular analysis on prognostic scores in essential thrombocythemia: a single center prospective cohort experience.

Authors:  Damien Luque Luque Paz; Olivier Mansier; Jérémie Riou; Carole Conejero; Lydia Roy; Célia Belkhodja; Valérie Ugo; Stéphane Giraudier
Journal:  Haematologica       Date:  2018-10-18       Impact factor: 9.941

Review 2.  High-throughput sequencing for noninvasive disease detection in hematologic malignancies.

Authors:  Florian Scherer; David M Kurtz; Maximilian Diehn; Ash A Alizadeh
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

Review 3.  Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches.

Authors:  Karl Haslam; Stephen E Langabeer
Journal:  Biomed Res Int       Date:  2016-10-20       Impact factor: 3.411

4.  IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association.

Authors:  Houria Debarri; Delphine Lebon; Christophe Roumier; Meyling Cheok; Alice Marceau-Renaut; Olivier Nibourel; Sandrine Geffroy; Nathalie Helevaut; Philippe Rousselot; Bérengère Gruson; Claude Gardin; Marie-Lorraine Chretien; Shéhérazade Sebda; Martin Figeac; Céline Berthon; Bruno Quesnel; Nicolas Boissel; Sylvie Castaigne; Hervé Dombret; Aline Renneville; Claude Preudhomme
Journal:  Oncotarget       Date:  2015-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.